Skip to main content

Prevention

What's new

The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the largest conference in diabetes, including automated insulin delivery, continuous glucose monitoring, extremely promising drugs in development, and more. Continue Reading »

Wegovy, a once-weekly injectable medication (semaglutide), has been approved by the FDA to treat obesity and excess weight – conditions that can lead to type 2 diabetes and prediabetes. This new treatment has led to significant weight loss in clinical trials; expected to be available in the US this month. Continue Reading »

Provention Bio’s new injectable drug was recommended by an FDA committee for approval on May 25, 2021. Studies show that Teplizumab can delay, for people at risk for type 1, the onset of the condition for two years or more. Learn what happened at the FDA meeting and what might come next. Continue Reading »

There are many things you can do to lower your risk of heart disease and stroke. One easy thing is to track the critical numbers that give you an accurate picture of your health – BMI & waist circumference, blood pressure, A1C, cholesterol, and kidney function. Continue Reading »

Omada Health is launching a physician-guided care program for people with diabetes and high blood pressure. Through the app, members will have access to physicians, health coaches, and diabetes care and education specialists, and will be able to see their health data and make medication changes. Continue Reading »

New results on Eylea, a treatment for diabetes-related retinopathy, show that the therapy reduces the risk of more serious eye complications when used for prevention. Continue Reading »

The US Preventive Services Task Force (USPSTF) has updated its recommendations, encouraging prediabetes and type 2 diabetes screening for people with excess weight or obesity starting at age 35. It also encourages the use of preventive lifestyle interventions when possible. Continue Reading »

Emerging evidence shows that variability in your A1C level may put you at a higher risk of stroke and heart disease.  Continue Reading »

Pages